Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X, Wang M, Zheng Y, Wang N, Wu Y, Ding C, Jia X, Yang R, Geng M, Chen Z, Zhang S, Zhang K, Li Y, Liu J, Gu J, Liao Y, Fan J, Shi H.
Han X, et al. Among authors: wang n, wang m.
Eur Radiol. 2024 Apr;34(4):2716-2726. doi: 10.1007/s00330-023-10241-x. Epub 2023 Sep 22.
Eur Radiol. 2024.
PMID: 37736804